Staying Vigilant for Immunocompromised Patients: Insights from a COVID-19 Expert Working Group
The unmet needs of immunocompromised patients post-COVID 19 | POLITICOПодробнее
Effect of COVID-19 XBB1.5 and BQ.1 Subvariants on Immunocompromised PatientsПодробнее
Immunocompromised patients could host COVID-19 for longer periodsПодробнее
What are experts saying about COVID-19 treatment in 2023?Подробнее
The Terrifying Reality of Being Immunocompromised During COVID-19 | Amanpour and CompanyПодробнее
LIVE: Ask the Experts – COVID-19 Vaccine Boosters for Cancer PatientsПодробнее
Third Doses of the COVID-19 Vaccines Expert Q&AПодробнее
Ask an MS Expert: COVID-19 Pandemic to EndemicПодробнее
Navigating Immunocompromised Conditions: How to Protect Yourself & Your FamilyПодробнее
Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised PeopleПодробнее
2022 International Day of Immunology - Science, State and Challenges of COVID-19 vaccinesПодробнее
COVID-19 travel trips for people with weakened immune systemsПодробнее
Should Immunocompromised People Get the COVID Vaccine?Подробнее
Coronavirus Pandemic Update 54: COVID-19 Antibody vs. PCR Testing; When to Relax Social Distancing?Подробнее
UCSF Experts on the Epidemiology, Science, & Clinical Manifestations of COVID-19, and UCSF ResponseПодробнее
COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Treatment and VaccinesПодробнее
COVID-19 and Antivirals: Expert Evaluation of Data in High-Risk Patient PopulationsПодробнее
LIVE: Chris Whitty attends Covid-19 inquiry hearingПодробнее
Newly FDA-approved COVID-19 treatment helps protect immunocompromisedПодробнее